Dr. H. Uri Saragovi
April 2016Research at the Lady Davis Institute

New hope for dry eye sufferers

People who suffer from chronic dry eye disease have new hope for relief, with the development of a promising treatment.

READ MORE →
Dr. Lawrence Rosenberg
April 2016Research at the Lady Davis Institute

Landmark clinical trial under way for type 1 diabetes treatment

Patients with long-standing type 1 diabetes are undergoing a clinical trial for a therapeutic approach that combines an agent for stimulating the growth of insulin-secreting cells in the pancreas, along with a drug to prevent the autoimmune system from rejecting the newly formed cells.

READ MORE →
Spyridoula Xenocostas
April 2016Research at the Lady Davis Institute

Developing social research to advance clinical practice

For Spyridoula Xenocostas, the practical applications of research hold abundant promise for healthcare users.

READ MORE →
At a session organized by the Jewish Public Library, author/researcher Maria Guzzo meets with secondary students at United Talmud Torah School to talk about emotional expression.
April 2016Research at the Lady Davis Institute

New attempt to understand the positive impact of expressive writing

A Montreal author and researcher is undertaking an in-depth study to determine how and why a positive impact is made through expressive writing.

READ MORE →
Dr. William Foulkes
Research at the Lady Davis InstituteSeptember 2015

Warning against “genetic over-diagnosis” in breast cancer screening

It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.

READ MORE →
Dr. Christoph Borchers
Research at the Lady Davis InstituteSeptember 2015

Pioneering effort to apply novel biotechnology to cancer research

The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.

READ MORE →
Dr. Andréa LeBlanc
Research at the Lady Davis InstituteSeptember 2015

New revelations about a possible pathway to Alzheimer’s disease

Elevated levels of a particular protein, known as Capase-6, in a specific area of the brain can serve as an early indicator for the onset of the type of cognitive impairment that is characteristic of Alzheimer’s disease.

READ MORE →
Dr. Samy Suissa
Research at the Lady Davis InstituteSpring 2015

Link found between pain reliever
and hypoglycemia

Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.

READ MORE →
Among those at the Psychiatry Research Day were (back row, from left) Dr. David Dunkley, a JGH psychiatry researcher; Anita David of the Gustav Levinschi Foundation; Dr. Phyllis Zelkowitz, Director of Research in the JGH Department of Psychiatry; and Dr. Karl Looper, JGH Chief of Psychiatry; as well as (front row, from left) Dr. Joel Paris, a JGH Research Associate; Dr. Mimi Israel, discussant; Dr. Zeev Rosberger, Director of the JGH Division of Psychology; and LDI researcher Dr. Danielle Groleau.
Research at the Lady Davis InstituteSpring 2015

Focus on teenagers in milestone
Psychiatry Research Day

The JGH’s annual Psychiatry Research Day hit its milestone 10th anniversary this year, with a day in March devoted to examining the various ways that teenagers and adolescents use and sometimes abuse their bodies.

READ MORE →
Dr Christoph Borchers
Research at the Lady Davis InstituteSpring 2015

Partnership supports cancer-fighting
power of protein analysis

Dr. Christoph Borchers has established the first pan-Canadian proteomics program, custom-tailoring cancer treatments to meet the needs of individual patients

READ MORE →